Skip to main content
UniHealth

Doctor search

Michael Gentoshi Ozawa, MD

Pathology · Stanford

NPI 1891052015

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2
Since medical school
14 years
University of Texas Medical School at Houston, 2012

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ozawa’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A128524 · Current

Licensed to practise in California · since 2014 · expires 2028-01-31 · University of Texas Medical School at Houston.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$109,448

Medicare paid this office $109,448 for 755 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Pathology examination of tissue using a microscope, intermediate complexity385$22,561$33
Evaluation of fine needle aspirate with interpretation and report190$17,043$62
Special stained specimen slides to examine tissue, each additional procedure178$15,515$25
Pathology examination of tissue using a microscope, moderately high complexity47$7,041$74
Surgical pathology consultation and report on referred slides prepared elsewhere91$6,835$73
See all 20 services
Every Original Medicare service billed
Pathology examination of tissue using a microscope, intermediate complexity385$22,561$33
Evaluation of fine needle aspirate with interpretation and report190$17,043$62
Special stained specimen slides to examine tissue, each additional procedure178$15,515$25
Pathology examination of tissue using a microscope, moderately high complexity47$7,041$74
Surgical pathology consultation and report on referred slides prepared elsewhere91$6,835$73
Special stained specimen slides to examine tissue, initial procedure204$6,822$31
Cell examination of specimen, selective cellular enhancement technique171$4,404$24
Evaluation of fine needle aspirate122$4,068$32
Pathology examination of tissue using a microscope, high complexity27$3,799$131
Microscopic genetic analysis of tumor, manual68$3,129$37
Special stained specimen slides to identify organisms including interpretation and report64$3,055$24
Pathology examination of specimen during surgery, first tissue block21$2,809$56
Fine needle aspiration biopsy using ultrasound guidance, first growth43$2,750$64
Surgical pathology consultation and report on referred material requiring preparation of slides25$1,988$80
Genetic sequencing localization, initial procedure35$1,461$38
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode38$1,099$20
Special stained specimen slides to examine tissue including interpretation and report41$924$11
Preparation of tissue for examination by removing any calcium present45$624$11
Pathology examination of tissue using a microscope, moderately low complexity45$591$10
Cell examination of specimen, concentration technique19$384$20

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Fine needle aspiration biopsy using ultrasound guidance, first growth472924303543
Fine needle aspiration biopsy, first growth2714––––

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

755 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 10% · Women 52% · Also on Medicaid 23% · Health risk score 1.66. Above the middle of the specialty; the typical pathology clinician is at 1.55.

Conditions among them: High blood pressure 75% · Cancer 41% · Diabetes 36% · Coronary heart disease 33% · Chronic kidney disease 31% · Atrial fibrillation 24% · Heart failure 20% · COPD 20% · Depression 19% · Stroke 11% · Dementia 7%.

The office billed $1,490,008, Medicare allowed $138,390 and paid $109,448; for 3,029 services of 33 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20247553,029741.66$1,490,008$109,448
20238023,019731.70$1,262,894$114,940
20227982,932741.70$1,050,759$117,929
20218683,186731.73$853,960$126,562
20207352,426741.70$663,080$94,187
20199273,156731.87$913,085$129,180
20183331,182721.44$320,474$49,229

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 25 services

Original Medicare services billed in 2023
Evaluation of fine needle aspirate with interpretation and report244$22,791$64
Pathology examination of tissue using a microscope, intermediate complexity368$21,001$34
Special stained specimen slides to examine tissue, each additional procedure171$15,137$26
Special stained specimen slides to examine tissue, initial procedure212$7,344$32
Surgical pathology consultation and report on referred slides prepared elsewhere84$6,623$78
Cell examination of specimen, selective cellular enhancement technique236$6,395$25
Evaluation of fine needle aspirate153$5,577$33
Pathology examination of tissue using a microscope, moderately high complexity32$5,013$73
Pathology examination of specimen during surgery, first tissue block22$3,672$58
Pathology examination of tissue using a microscope, high complexity21$3,267$136
Microscopic genetic analysis of tumor, manual62$3,226$38
Fine needle aspiration biopsy using ultrasound guidance, first growth35$2,324$66
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode51$1,561$20
Surgical pathology consultation and report on referred material requiring preparation of slides18$1,468$82
Special stained specimen slides to identify organisms including interpretation and report36$1,455$25
Genetic sequencing localization, initial procedure34$1,444$40
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure11$881$59
Special stained specimen slides to examine tissue including interpretation and report34$752$11
Special stained specimen slides to examine tissue, each multiplex procedure19$712$36
Pathology cytologic examination of specimen during surgery, initial site12$699$58
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician17$501$29
Genetic sequencing localization, each additional procedure11$412$32
Pathology examination of tissue using a microscope, moderately low complexity26$397$10
Cell examination of specimen, concentration technique13$293$21
Preparation of tissue for examination by removing any calcium present24$287$11

2022: 24 services

Original Medicare services billed in 2022
Pathology examination of tissue using a microscope, intermediate complexity355$20,302$35
Evaluation of fine needle aspirate with interpretation and report195$19,310$65
Pathology examination of tissue using a microscope, moderately high complexity68$11,419$77
Special stained specimen slides to examine tissue, each additional procedure121$10,885$26
Pathology examination of specimen during surgery, first tissue block53$7,443$59
Surgical pathology consultation and report on referred slides prepared elsewhere95$7,368$76
Cell examination of specimen, selective cellular enhancement technique258$6,498$24
Special stained specimen slides to examine tissue, initial procedure167$6,064$32
Evaluation of fine needle aspirate131$5,355$33
Pathology examination of tissue using a microscope, high complexity33$4,911$136
Special stained specimen slides to identify organisms including interpretation and report61$2,544$24
Microscopic genetic analysis of tumor, manual51$2,254$39
Fine needle aspiration biopsy using ultrasound guidance, first growth29$1,881$63
Flow cytometry technique for dna or cell analysis, 16 or more markers20$1,622$77
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode43$1,615$20
Genetic sequencing localization, initial procedure28$1,181$41
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure13$1,174$59
Surgical pathology consultation and report on referred material requiring preparation of slides15$1,144$76
Special stained specimen slides to examine tissue including interpretation and report34$795$11
Pathology examination of specimen during surgery, each additional tissue block12$489$29
Preparation of tissue for examination by removing any calcium present35$465$12
Cell examination of body fluid, smears13$379$25
Cell examination of specimen, concentration technique17$318$19
Pathology examination of tissue using a microscope, moderately low complexity24$307$11

2021: 24 services

Original Medicare services billed in 2021
Pathology examination of tissue using a microscope, intermediate complexity394$22,921$36
Special stained specimen slides to examine tissue, each additional procedure156$15,032$27
Evaluation of fine needle aspirate with interpretation and report138$12,068$67
Pathology examination of specimen during surgery, first tissue block68$11,037$60
Pathology examination of tissue using a microscope, moderately high complexity70$11,022$78
Surgical pathology consultation and report on referred slides prepared elsewhere106$8,412$79
Cell examination of specimen, selective cellular enhancement technique303$8,357$26
Special stained specimen slides to examine tissue, initial procedure179$6,659$33
Pathology examination of tissue using a microscope, high complexity34$5,188$140
Evaluation of fine needle aspirate106$4,497$34
Surgical pathology consultation and report on referred material requiring preparation of slides37$3,055$83
Special stained specimen slides to identify organisms including interpretation and report56$2,997$25
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure28$2,713$60
Microscopic genetic analysis of tumor, manual52$2,603$40
Fine needle aspiration biopsy using ultrasound guidance, first growth24$1,594$66
Special stained specimen slides to examine tissue including interpretation and report55$1,178$11
Genetic sequencing localization, initial procedure23$1,079$41
Flow cytometry technique for dna or cell analysis, 16 or more markers11$948$79
Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode24$711$21
Preparation of tissue for examination by removing any calcium present49$698$12
Pathology examination of specimen during surgery, each additional tissue block15$653$30
Cell examination of specimen, concentration technique23$603$22
Pathology examination of tissue using a microscope, moderately low complexity33$595$11
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening13$415$32

2020: 21 services

Original Medicare services billed in 2020
Pathology examination of tissue using a microscope, intermediate complexity276$15,018$36
Special stained specimen slides to examine tissue, each additional procedure127$14,543$28
Evaluation of fine needle aspirate with interpretation and report144$11,217$68
Cell examination of specimen, selective cellular enhancement technique339$9,286$25
Surgical pathology consultation and report on referred slides prepared elsewhere102$8,410$79
Special stained specimen slides to examine tissue, initial procedure147$5,549$34
Pathology examination of tissue using a microscope, moderately high complexity33$5,018$81
Pathology examination of specimen during surgery, first tissue block27$4,662$61
Evaluation of fine needle aspirate73$2,979$35
Microscopic genetic analysis of tumor, manual42$2,172$41
Pathology examination of tissue using a microscope, high complexity14$2,130$142
Flow cytometry technique for dna or cell analysis, 16 or more markers23$1,853$81
Fine needle aspiration biopsy using ultrasound guidance, first growth29$1,849$64
Surgical pathology consultation and report on referred material requiring preparation of slides20$1,670$83
Special stained specimen slides to identify organisms including interpretation and report26$1,388$26
Special stained specimen slides to examine tissue including interpretation and report40$887$12
Genetic sequencing localization, initial procedure17$730$43
Fine needle aspiration biopsy, first growth14$710$51
Pathology examination of tissue using a microscope, moderately low complexity36$544$11
Cell examination of specimen, concentration technique21$520$22
Preparation of tissue for examination by removing any calcium present19$250$11

2019: 23 services

Original Medicare services billed in 2019
Pathology examination of tissue using a microscope, intermediate complexity401$21,116$36
Evaluation of fine needle aspirate with interpretation and report230$19,637$67
Pathology examination of tissue using a microscope, moderately high complexity71$13,261$79
Special stained specimen slides to examine tissue, each additional procedure131$11,527$27
Pathology examination of specimen during surgery, first tissue block61$9,432$60
Surgical pathology consultation and report on referred slides prepared elsewhere116$8,882$77
Cell examination of specimen, selective cellular enhancement technique283$7,753$25
Special stained specimen slides to examine tissue, initial procedure172$6,432$34
Evaluation of fine needle aspirate104$3,983$34
Pathology examination of tissue using a microscope, high complexity26$3,770$140
Special stained specimen slides to identify organisms including interpretation and report80$3,582$25
Microscopic genetic analysis of tumor, manual60$3,320$40
Fine needle aspiration biopsy using ultrasound guidance, first growth47$3,043$65
Surgical pathology consultation and report on referred material requiring preparation of slides27$2,213$82
Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure17$1,797$60
Special stained specimen slides to examine tissue including interpretation and report64$1,376$11
Fine needle aspiration biopsy, first growth27$1,322$49
Flow cytometry technique for dna or cell analysis, 9 to 15 markers19$1,124$59
Genetic sequencing localization, initial procedure24$1,074$41
Pathology examination of tissue using a microscope, moderately low complexity55$832$11
Preparation of tissue for examination by removing any calcium present51$711$12
Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening15$470$31
Cell examination of specimen, concentration technique13$297$21

2018: 14 services

Original Medicare services billed in 2018
Evaluation of fine needle aspirate with interpretation and report131$12,382$68
Pathology examination of tissue using a microscope, intermediate complexity140$7,263$36
Special stained specimen slides to examine tissue, each additional procedure56$5,651$27
Surgical pathology consultation and report on referred slides prepared elsewhere45$3,554$79
Cell examination of specimen, selective cellular enhancement technique109$2,981$27
Special stained specimen slides to examine tissue, initial procedure73$2,843$34
Pathology examination of specimen during surgery, first tissue block12$2,613$61
Evaluation of fine needle aspirate50$1,907$35
Microscopic genetic analysis of tumor, manual20$1,236$43
Fine needle aspiration using imaging guidance16$1,172$59
Special stained specimen slides to identify organisms including interpretation and report22$1,092$25
Fine needle aspiration biopsy, first growth14$926$62
Special stained specimen slides to examine tissue including interpretation and report21$406$11
Cell examination of specimen, concentration technique11$237$22

Medicaid work

$14,026 in 2024

Medicaid paid $14,026 for 395 billed services this clinician did in 2024, up to 30 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
TISSUE EXAM BY PATHOLOGIST185$6,442
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT66$3,128
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure54$2,149
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal56$1,514
IMHCHEM/IMCYTCHM EA ADD ANTB21$534
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site13$259
Medicaid work by year
2024395630$14,026
2023469634$14,289
2022353629$11,051
2021399629$12,218
2020221331$5,052
2019143317$3,984
201824212$1,007
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
TISSUE EXAM BY PATHOLOGIST211$6,139
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT91$3,517
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal72$1,651
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure34$1,176
IMHCHEM/IMCYTCHM EA ADD ANTB28$1,102
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site33$704

2022

Largest Medicaid services in 2022
TISSUE EXAM BY PATHOLOGIST149$4,551
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT61$2,894
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure40$1,214
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal78$1,153
IMHCHEM/IMCYTCHM EA ADD ANTB12$949
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site13$290

2021

Largest Medicaid services in 2021
TISSUE EXAM BY PATHOLOGIST191$6,488
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal122$2,198
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT30$1,692
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure29$1,146
IMHCHEM/IMCYTCHM EA ADD ANTB14$376
Cytopathology, evaluation of fine needle aspirate; immediate cytohistologic study to determine adequacy for diagnosis, first evaluation episode, each site13$318

2020

Largest Medicaid services in 2020
TISSUE EXAM BY PATHOLOGIST89$2,351
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal117$2,264
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT15$437

2019

Largest Medicaid services in 2019
TISSUE EXAM BY PATHOLOGIST93$2,794
Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal38$799
Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure12$391

2018

Largest Medicaid services in 2018
CYTP EVAL FINE NEEDLE ASPIRATE INTERP & REPORT12$600
TISSUE EXAM BY PATHOLOGIST12$406

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1891052015
Licence
CA A128524California A128524: Current · expires 2028-01-31
Trained
University of Texas Medical School at Houston, 2012 · 14 years ago
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207ZP0102X (207ZP0102X); Federal specialty code 207ZC0500X (207ZC0500X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2012-04-12
NPI last updated
2024-03-13
NPI record certified
2024-03-13

This is when the NPI record was last certified, not a medical board exam.